课题基金 / 基金详情

SIMULATION OF IV DRUG INTERVENTIONS ON HIV INFECT/AIDS

SIMULATION OF IV DRUG INTERVENTIONS ON HIV INFECT/AIDS
HIV 感染/艾滋病静脉药物干预模拟
批准号:
3211260
负责人:
Philip C Cooley
金额:
$29.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1992-08-31

项目摘要

项目成果

Philip C Cooley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The major objectives of the proposed research are to: revise the model we have previously developed to incorporate recent advances in knowledge of the epidemiology of HIV/AIDS and changes introduced by both drug prophylaxis/treatment and behavioral change; use the model to explore and expand our understanding of the natural history of HIV/AIDS with particular emphasis on establishing rate of disease progression in IVDUs; and perform a set of policy analyses that would allow HIV prevention approaches to be evaluated in the context of drug treatment and/or HIV counseling programs. Recent use of antivirals and prophylactic measures have altered the incubation and survival functions--crucial parameters for any model that will be used for forecasting HIV and AIDS prevalence. Using data which have become available from the National Institute of Allergies and Infectious Diseases (NIAID) under the AIDS Clinical Trials Coordinating Center project, we propose to revise these parameters and make short-term forecasts of HIV seroprevalence and AIDS incidence. Two other sources of data are NIDA's AIDS Targeted Outreach Program and CDC's HIV counseling and Treatment Evaluation Study. Interventions under these program will yield data on changes in drug-use behavior and sexual practices. These changes are especially relevant for intravenous drug abusers. When details on drug abuse behavior are supplied to the revised model, the effect of various intervention strategies on the current epidermic will be evaluated. The HIV/AIDS prevalence model developed by RTI includes the following characteristics: all primary risk groups are represented; risk group size is based on AIDS incidence data that accounts for risk behaviors, thereby estimating only those with high risk behaviors; and contacts that result in infection are treated as endogenous model parameters so that changes in risk group behavior are implicitly measured. As a result, the model avoids the pitfalls of many of the models reported in the literature that treat contact rate a known exogenous parameters.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The assumption of no long reporting delays may result in underestimates of US AIDS incidence.
假设没有长期报告延迟可能会导致美国艾滋病发病率的低估。
DOI: 10.1097/00002030-199310000-00012
发表时间: 1993
期刊: AIDS (London, England)
影响因子: --
作者: [Cooley,PC, Hamill,DN, Myers,LE, Liner,EC]
通讯作者: Liner,EC
How can results of longitudinal studies help mathematicians model the HIV epidemic among intravenous drug abusers and the general population?
纵向研究的结果如何帮助数学家模拟静脉注射毒品滥用者和普通人群中的艾滋病毒流行情况?
DOI: --
发表时间: 1991
期刊: NIDA research monograph
影响因子: --
作者: [Cooley,PC, Hamill,DN, Reade-Christopher,SJ, Liner,EC, vanderHorst,CM]
通讯作者: vanderHorst,CM
MIDAS ITR Extension
  • 批准号:
    8848244
  • 项目类别:
  • 资助金额:
    $9.96万
  • 财政年份:
    2014
  • 负责人:
    Philip C Cooley
  • 依托单位:
Modeling of Infectious Disease Agent Study Information Technology
  • 批准号:
    8481558
  • 项目类别:
  • 资助金额:
    $190.71万
  • 财政年份:
    2009
  • 负责人:
    Philip C Cooley
  • 依托单位:
SIMULATION OF IV DRUG EFFECTS ON HIV INFECTIONS AND AIDS
  • 批准号:
    3211259
  • 项目类别:
  • 资助金额:
    $22.02万
  • 财政年份:
    1987
  • 负责人:
    Philip C Cooley
  • 依托单位:
IMULATION OF IV DRUG INTERVENTIONS ON HIV INFECTIONS &
  • 批准号:
    3211258
  • 项目类别:
  • 资助金额:
    $28.87万
  • 财政年份:
    1987
  • 负责人:
    Philip C Cooley
  • 依托单位:
海外基金